تحميل...
Radiofrequency ablation in combination with an mTOR inhibitor restrains pancreatic cancer growth induced by intrinsic HSP70
BACKGROUND: Radiofrequency ablation (RFA) is widely used in palliative therapy of malignant cancers. Several studies have shown its applicability and safety for locally advanced pancreatic cancer (LAPC). The objective of this study was to modify the current regimen to improve its therapeutic effect....
محفوظ في:
الحاوية / القاعدة: | Ther Adv Med Oncol |
---|---|
المؤلفون الرئيسيون: | , , , , , , , , , , , , , , |
التنسيق: | Artigo |
اللغة: | Inglês |
منشور في: |
SAGE Publications
2020
|
الموضوعات: | |
الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7491221/ https://ncbi.nlm.nih.gov/pubmed/32973929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920953728 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|